The controller-to-total asthma medication ratio is associated with patient-centered as well as utilization outcomes

Chest

Volumn 130, Issue 1, 2006, Pages 43-50

  Schatz, Michael ^a,e   Zeiger, Robert S ^a   Vollmer, William M ^b   Mosen, David ^a   Mendoza, Guillermo ^a   Apter, Andrea J ^c   Stibolt, Thomas B ^a   Leong, Albin ^a   Johnson, Michael S ^a   Cook, E Francis ^d  

^a KAISER PERMANENTE   (United States)

^b CENTER FOR HEALTH RESEARCH   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

Asthma; Asthma population management; Asthma quality of care; Inhaled corticosteroids; Medication ratio; agonists

Indexed keywords

ANTIASTHMATIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; NEDOCROMIL;

ADULT; ARTICLE; ASTHMA; DEMOGRAPHY; DISEASE EXACERBATION; DISEASE SEVERITY; EMERGENCY WARD; FEMALE; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; SYMPTOMATOLOGY; TREATMENT OUTCOME; VALIDATION PROCESS;

EID: 33746342466     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.130.1.43     Document Type: Article

References (34)

1. Mannino DM, Homa DM, Akmbami LJ, et al. Surveillance for asthma: United States, 1980-1999. MMWR Morb Mortal Wkly Rep 2002; 51:1-13
2. Weiss WB, Sullivan SD. The health economics of asthma and rhinitis: I. Assessing the economic impact. J Allergy Clin Immunol 2001; 107:3-8
3. Bateman ED, Boushey HA, Bousquet J, et al. Can guideline-defined asthma control be achieved. Am J Respir Crit Care Med 2004; 170:836-844
4. Adams RJ, Fuhlbrigge A, Guilbert T, et al. Inadequate use of asthma medication in the United States; results of the Asthma in America national population survey. J Allergy Clin Immunol 2002; 110:58-64
5. Fuhlbrigge AL, Adams RJ, Guilbert TW, et al. The burden of asthma in the United States: level and distribution are dependent on interpretation of the national asthma education and prevention program guidelines. Am J Respir Crit Care Med 2002; 166:1044-1049
6. Boulet L-P, Phillips R, O'Byrne P, et al. Evaluation of asthma control by physicians and patients: comparison with current guidelines. Can Respir J 2002; 9:417-423
7. National Asthma Education and Prevention Program. Expert panel report: guidelines for the diagnosis and management of asthma. Bethesda, MD: National Institutes of Health, 1991; NIH Publication No. 91-3642
8. National Asthma Education and Prevention Program. Expert panel report 2: guidelines for the diagnosis and management of asthma. Bethesda, MD: National Institutes of Health, 1997; NIH Publication No. 02-4051
9. National Asthma Education and Prevention Program. Expert panel report: guidelines for the diagnosis and management of asthma: update on selected topics; 2002. J Allergy Clin Immunol 2002; 110:8141-8219
10. National Committee for Quality Assurance. HEDIS 2002: technical specifications (vol 2). Washington, DC: National Committee for Quality Assurance, 2001
11. Schatz M, Nakahiro R, Crawford W, et al. Asthma quality of care markers using administrative data. Chest 2005; 128:1968-1973
12. Schatz M, Mosen D, Apter AJ, et al. Relationships between quality of life, severity, and control measures in asthma: an evaluation using factor analysis. J Allergy Clin Immunol 2005; 115:1049-1055
13. Juniper EF, Guyatt GH, Cox FM, et al. Development and validation of the Mini Asthma Quality of Life Questionnaire. Eur Respir J 1999; 5:35-46
14. Vollmer WM, Markson LE, O'Connor E, et al. Association of asthma control with health care utilization and quality of life. Am J Respir Crit Care Med 1999; 160:1647-1652
15. Bayliss MS, Espindle DM, Ware JE. Asthma Outcomes Monitoring System (AOMS) administration, scoring, and interpretation manual. Lincoln, RI: QualityMetric, 1999
16. Schatz M, Mosen D, Apter AJ, et al. The relationship of validated psychometric tools to subsequent medical utilization for asthma. J Allergy Clin Immunol 2005; 115:564-570
17. Juniper EF, Guyatt GH, Fernie PJ, et al. Measuring quality of life in asthma. Am Rev Respir Dis 1993; 147:832-838
18. Schatz M, Nakahiro R, Jones CH, et al. Asthma population management: development and validation of a practical 3-level risk stratification scheme. Am J Manag Care 2004; 10:25-32
19. Gottlieb DJ, Beiser AS, O'Connor GT. Poverty, race, and medication use are correlates of asthma hospitalization rates. Chest 1995; 108:28-35
20. Sturdy P, Naish J, Pereira F, et al. Characteristics of general practices that prescribe appropriately for asthma. BMJ 1995; 311:1547-1548
21. Shelley M, Croft P, Chapman S, et al. Is the ratio of inhaled corticosteroid to bronchodilator a good indicator of the quality of asthma prescribing? Cross sectional study linking prescribing data to data on admissions. BMJ 1996; 313:1124-1126
22. Griffiths C, Naish J, Sturdy P, et al. Prescribing and hospital admissions for asthma in east London. BMJ 1996; 312:481-482
23. Aveyard P. Assessing the performance of general practices caring for patients with asthma. Br J Gen Pract 1997; 47:423-426
24. Lang DM, Sherman MS, Polanisky M. Guidelines and relations of asthma management. Arch Intern Med 1997; 157:1193-2000
25. Frischer M, Heatlie H, Chapman S, et al. Should the corticosteroid to bronchodilator ratio be promoted as a quality prescribing marker? Public Health 1999; 113:247-250
26. Shelley M, Croft P, Chapman S, et al. Is the quality of asthma prescribing, as measured by the general practice ratio of corticosteroid to bronchodilator, associated with asthma morbidity? J Clin Epidemiol 2000; 53:1217-1221
27. Lieu TA, Capra AM, Quesenberry CP, et al. Computer-based models to identify high-risk adults with asthma: is the glass half empty or half full? J Asthma 1999; 36:359-370
28. Fuhlbrigge A, Carey VJ, Adams RJ, et al. Evaluation of asthma prescription measures and health system performance based on emergency department utilization. Med Care 2004; 42:465-471
29. Salamzadeh J, Wong ICK, Hosker HSR, et al. The relationship between the quality of prescribing and practice appointment rates with asthma management data in those admitted to hospital due to an acute exacerbation. Respir Med 2005; 99:735-741
30. Mosen D, Macy E, Schatz M, et al. How well do the HEDIS asthma inclusion criteria identify persistent asthma? Am J Manag Care 2005; 11:650-654
31. Milgrom H, Bender B, Wamboldt F. Assessing adherence with asthma medication: making the counts count. Ann Allergy Asthma Immunol 2002; 88:429-431
32. Sherman J, Hutson A, Baumsein S, et al. Telephoning the patient's pharmacy to access adherence with asthma medications by measuring refill rate for prescriptions. J Pediatr 2000; 136:532-536
33. Juniper EF, Svensson K, Mork A-C, et al. Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir Med 2005; 99:553-558
34. Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 2004; 113:59-65